MeQuilibrium, a provider of digital resilience solutions to employers, has acquired the assets of science-based breathing app, Resilio. This acquisition introduces biometric technology into the MeQuilibrium platform. Resilio provides biofeedback to users.
“This acquisition accelerates our company’s growth with the addition of biometrics capabilities through the use of the most ubiquitous device today — the smartphone,” said Jan Bruce, CEO and co-founder, MeQuilibrium. “Integration into our core platform provides an additional and ultimately reflexive breathing and stress management intervention for anxiety, sleep, and burnout.”
“We built Resilio to be a human-centric, portable, easy-to-use app for everyone because it focuses on strengthening your nervous system and builds the foundation for resilience from a physiological point of view,” said Anders Søndergaard, Resilio co-founder. “We are thrilled that this technology will be integrated into the MeQuilibrium resilience suite. With MeQuilibrium, we can achieve a greater impact in helping people be more resilient and reach hundreds of thousands of users around the globe.”